Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer
Titel:
Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer
Auteur:
Schneider, Bryan J. Kalemkerian, Gregory P. Gadgeel, Shirish M. Valdivieso, Manuel Hackstock, Deborah M. Chen, Wei Heilbrun, Lance K. Ruckdeschel, John C. Wozniak, Antoinette J.